Oxford Immune Algorithmics is a biotech company incubated by the University of Oxford specialised in deep tech and A.I. for remote blood testing and analytics that complements and goes beyond current trends for online medical services.

(c) 2020 Oxford Immune Algorithmics, all rights reserved

---

Harmonised ​ISO 14971/DCB0129
​​Patents pending GB1918950.5 and GB1918948.9

Algocyte® relieves clinicians of time-consuming tasks particularly true when dealing with large backlogs inherited from the pandemic emergency.

Algocyte® is particularly useful to vulnerable patients who may put themselves at risk of infection (e.g. COVID-19) when visiting hospitals or when forced to delay their treatment because they cannot be properly monitored before or after intervention.

---

Algocyte® is OIA's flagship product. A comprehensive CE-compliant medically-driven solution that exploits the power of responsible machine intelligence to support clinicians and healthcare professionals to automate:
​

• remote blood testing and analytics,
• smart health monitoring for decision support,
• patient triage based on test results,
• comparative analysis of treatment/drug response, and
• alerts based on patients' condition profiles and adaptive personalised baselines.​

​Algocyte's remote service features leads to better patient outcomes, reduction of costs by freeing up doctors' time and avoiding unnecessary trips by community nurses or sparing patients from having to come to hospital.

---

Request more information or a demonstration

---

Bridging academy & industry

---

​With over two thousand members, our AI meetup groups in the UK are among the largest in their cities and demonstrate our commitment to connecting the academic and industrial communities and bring responsible AI to healthcare:

---

Reading

London

Oxford

Partners & collaborators

---

---

Investors & sponsors